Compounds for the treatment of neurological or mitochondrial diseases

Abstract

Compounds and methods are provided for the treatment of neurological or mitochondrial diseases, including epilepsy. In some embodiments, the compounds are substituted 1,4-naphthoquinones.

1 - 54 . (canceled) 
     
     
         55 . A compound of the formula: 
       
         
           
           
               
               
           
         
         or a pharmaceutically acceptable salt thereof. 
       
     
     
         56 . The compound of  claim 55  further defined as: 
       
         
           
           
               
               
           
         
       
     
     
         57 . A pharmaceutical composition of  claim 55  comprising:
 (A) a compound of the formula: 
 
       
         
           
           
               
               
           
         
         
           or a pharmaceutically acceptable salt thereof; and 
         
         (B) an excipient. 
       
     
     
         58 . The pharmaceutical composition of  claim 57 , wherein the pharmaceutical composition is formulated for oral, sublingual, intranasal, intravenous, subcutaneous, parenteral, inhalation, or aerosol delivery. 
     
     
         59 . The pharmaceutical composition of  claim 57 , wherein the pharmaceutical composition is formulated as a unit dose.